menu
    • menu
    [{"orgOrder":0,"company":"WinSanTor","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Pirenzepine","moa":"Muscarinic acetylcholine receptor M1","graph1":"Neurology","graph2":"Phase II","graph3":"WinSanTor","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Solution","sponsorNew":"WinSanTor \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"WinSanTor \/ Undisclosed"},{"orgOrder":0,"company":"WinSanTor","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases | Eastern Virginia Medical School","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Pirenzepine","moa":"Muscarinic acetylcholine receptor M1","graph1":"Neurology","graph2":"Phase II","graph3":"WinSanTor","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"WinSanTor \/ National Institute of Diabetes and Digestive and Kidney Diseases | Eastern Virginia Medical School","highestDevelopmentStatusID":"8","companyTruncated":"WinSanTor \/ National Institute of Diabetes and Digestive and Kidney Diseases | Eastern Virginia Medical School"}]

    Find Clinical Drug Pipeline Developments & Deals for Pirenzepine

    Menu

    Pirenzepine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            WinSanTor

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            WinSanTor

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Pirenzepine

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : National Institute of Diabetes and Digestive and Kidney Diseases | Eastern Virginia Medical School

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral N...

                            Details : Pirenzepine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Diabetic Neuropathies.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            March 08, 2021

                            Lead Product(s) : Pirenzepine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : National Institute of Diabetes and Digestive and Kidney Diseases | Eastern Virginia Medical School

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            WinSanTor

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            WinSanTor

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Pirenzepine

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropath...

                            Details : Pirenzepine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Peripheral Nervous System Diseases.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            July 02, 2019

                            Lead Product(s) : Pirenzepine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth